This One Factor Keeps Me Buying Marvell Technology Now

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • MRVL fell 33% in one month while Q1 FY2027 revenue grew 28% YoY and free cash flow surged 127% to $483M.

  • CEO Matt Murphy raised both FY2027 and FY2028 revenue outlooks on exceptional AI bookings, with Q2 guiding to 35% year-over-year growth.

  • With 76% of revenue tied to a handful of hyperscalers, any major customer moving silicon in-house remains the single biggest threat to the thesis.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Marvell Technology didn't make the cut. Grab the names FREE today.

This One Factor Keeps Me Buying Marvell Technology Now

© Zapp2Photo / Shutterstock.com

My brokerage app knows the Marvell ticker by heart. When a stock I have been accumulating drops 33.02% in a month and the underlying business keeps accelerating, the decision writes itself.

That is the single factor pulling me back to Marvell Technology (NASDAQ:MRVL | MRVL Price Prediction): the market handed me a discount on an AI infrastructure semiconductor pure-play whose numbers still point the right direction. Shares closed at $207.96, well below the 52-week high of $329.80. Yet year to date the stock is up 145.07%, up 185.25% over one year, and up 1,811.10% over ten. This is a violent repricing inside a long uptrend, and I am adding to my cost basis at these prices.

The Data Behind My Conviction

Marvell’s most recent quarter (Q1 FY2027) posted revenue of $2.418 billion, up 27.6% year over year and ahead of consensus. Data center revenue reached $1.833 billion, 76% of the total, up 27% year over year and 11% sequentially. Free cash flow more than doubled to $483.1 million, up 126.8%, while cash on the balance sheet climbed to $3.84 billion. Full fiscal 2026 revenue landed at $8.195 billion, up 42%, and the company repurchased $2.04 billion of stock during that year.

Management is guiding Q2 FY27 revenue to $2.7 billion, roughly 35% year-over-year growth, and CEO Matt Murphy said Marvell is “significantly raising Marvell’s revenue outlook for both fiscal 2027 and fiscal 2028” on “exceptional AI-related bookings.” He expects growth to accelerate each quarter through fiscal 2027. Trailing P/E sits at 65, while forward P/E drops to 47, indicating the earnings ramp is driving valuation.

Why Marvell Stands Out

Every AI investor first reaches for mega-cap chip generalists. Marvell offers a concentrated bet on AI datacenter plumbing: custom XPU and XPU-attach silicon, plus 800G and 1.6T scale-out optics, 51.2T Ethernet scale-out switches, and scale-up NPO and CPO optical solutions. At a market cap of roughly $175 billion, every incremental hyperscaler design win moves the needle in a way it cannot at a generalist ten times the size. The Celestial AI and XConn acquisitions that closed in February 2026 add photonic fabric and chiplet connectivity directly to that thesis.

The Risk I Cannot Ignore

With 76% of revenue from data center and a small group of hyperscalers driving most of that, customer concentration is the real risk. If a major customer moves silicon fully in-house, this thesis takes a hit. Q1 also included a $331.8 million contingent consideration charge that pushed GAAP net income down 80.6% year over year. That is acquisition-related accounting noise rather than operating deterioration, and the raised multi-year guidance tells me the bookings pipeline is deep enough to absorb any single customer’s platform decisions.

Why the Buy Button Stays Active

Analyst consensus sits at a $253.69 target with 7 strong buy, 31 buy, 5 hold, and 1 strong sell ratings behind it. Marvell is compounding revenue in the high 20s heading toward the mid 30s, generating record cash, buying back stock, and sitting inside the fastest capex cycle of my investing life. The market decided it was too expensive. I decided it was on sale, and the buy button stays lit until the story changes.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

SMCI Vol: 89,500,809
DELL Vol: 3,555,444
EQT
EQT Vol: 6,546,784
CME Vol: 1,390,321

Top Losing Stocks

CTRA Vol: 73,319,495
GEV Vol: 2,088,647
TEL Vol: 3,203,289
NOW Vol: 10,544,606
DASH Vol: 1,104,501